Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To compare the effects of botulinum toxin A (BtA) versus anticholinergics in adults with cervical dystonia (CD). Background: This is an update of a…Results of the German registry of pediatric deep brain stimulation in patients with childhood-onset dyskinetic movement disorders (GEPESTIM)
Objective: We seek to systematically evaluate the clinical outcome of pediatric patients undergoing DBS at different stages of development. Background: Data on pediatric deep brain…A case with posttraumatic functional shoulder dyskinesia
Objective: Here we report a case with posttraumatic functional shoulder movement disorder. Background: Focal posttraumatic shoulder movement disorders are seen rarely. Focal posttraumatic movement disorder…Sarcopenia and dynapenia in patients with parkinsonism
Objective: The aims of the present study were to estimate prevalence of sarcopenia and dynapenia in patients with Parkinsonian syndromes and to investigate their association…The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients
Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis
Objective: The goal of this preliminary study is to introduce the technique of CardioPulmonary Coupling (CPC) to visualize and quantify the sleep spectrograms of Amyotrophic…Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution
Objective: To investigate the effects of physiotherapy treatment on functioning according to International Classification of Functioning, Disability and Health (ICF) framework in patients in early…Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia
Objective: To evaluate the role of the atypical vesicular glutamate transporter 3 (VGLUT3) and the vesicular acetylcholine transporter (VAChT) in L-DOPA-induced dyskinesia. Background: Parkinson's disease…An ongoing phase 2, multi-centre, open-label, study of WTX101 in Wilson disease patients – Early observations
Objective: The aim of this ongoing study is to evaluate the efficacy and safety of WTX101 in newly diagnosed Wilson Disease patients. Background: WTX101 (bis-choline…Supplement use in PD is associated with delayed initiation of dopaminergic therapy
Objective: To describe supplement use among early PD patients, and to determine its association with time to initiation of dopamine replacement therapy (DRT). Background: Earlier…
- « Previous Page
- 1
- …
- 74
- 75
- 76
- 77
- 78
- …
- 207
- Next Page »